Trial Profile
Randomised, Double Blind, Placebo Controlled Trial of Angiotensin Converting Enzyme Inhibitors and Statins in the Prevention of Long Term Complications in Young People With Type 1 Diabetes
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 07 Mar 2022
Price :
$35
*
At a glance
- Drugs Atorvastatin (Primary) ; Quinapril (Primary)
- Indications Diabetic nephropathies; Proteinuria
- Focus Therapeutic Use
- Acronyms AdDIT
- 22 Mar 2019 This trial has been completed in United Kingdom, according to European Clinical Trials Database.
- 10 Nov 2017 Status changed from active, no longer recruiting to completed.
- 02 Nov 2017 Results published in the New England Journal of Medicine